Cornerstone Capital Management Holdings’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-5,618	Closed	-$177K	–	1594
2015 Q3	$177K	Sell	5,618 -120	-2%	-$5.74K	﹤0.01%	1240
2015 Q2	$339K	Buy	5,738 +1,440	+34%	+$102K	﹤0.01%	1091
2015 Q1	$459K	Sell	4,298 -3,922	-48%	-$374K	﹤0.01%	1038
2014 Q4	$772K	Buy	8,220 +3,770	+85%	+$360K	0.01%	919
2014 Q3	$342K	Buy	4,450 +3,820	+606%	+$301K	﹤0.01%	1027
2014 Q2	$56K	Sell	630 -470	-43%	-$28.8K	﹤0.01%	1237
2014 Q1	$59K	Hold	1,100	–	–	﹤0.01%	1240
2013 Q4	$27K	Buy	1,100 +330	+43%	+$7.86K	﹤0.01%	1198
2013 Q3	$21K	Hold	770	–	–	﹤0.01%	1223
2013 Q2	$28K	Buy	+770	New	+$28.9K	﹤0.01%	1201

Other funds holding PTX

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Cornerstone Capital Management Holdings's PTX Position: Q4 2015 in Review

Cornerstone Capital Management Holdings sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q4 2015, closing a stake of 5,618 shares — an estimated $177K sold.

Cornerstone Capital Management Holdings first reported a position in PTX in Q2 2013 and held it in 10 quarters. The position peaked at $772K in Q4 2014. 101 funds tracked by Wall St. Rank hold PTX as of Q4 2015.

Cornerstone Capital Management Holdings reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q4 2015 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 5,618 Pernix Therapeutics Holdings, Inc. shares in Q4 2015, an estimated $177K.
Cornerstone Capital Management Holdings first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 10 quarters.
Cornerstone Capital Management Holdings's Pernix Therapeutics Holdings, Inc. position peaked at $772K in Q4 2014.
101 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q4 2015.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2015, filed 9 Feb 2016.